Form 4 for EYPT EyePoint, Inc.
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-09 · accession 0001562180-23-001337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-13 | 2023-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | +10.8K | 29.5K | +58% | $0 |
| DM | 2023-02-13 | 2023-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | F - Tax | $4.17 | -3,744 | 25.7K | -13% | -$15.6K |
| DM | 2023-02-13 | 2023-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | -10.8K | 11.7K | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | M | A | 4,967 | $0.00 | 23,618 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-09 | M | A | 5,833 | $0.00 | 29,451 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-09 | F | D | 2,022 | $4.17 | 27,429 | D | — | — | (F1) No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of their withholding right following the vesting of the restricted stock units. |
| 4 | Common | Common Stock | 2023-02-09 | F | D | 1,722 | $4.17 | 25,707 | D | — | — | (F1) No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of their withholding right following the vesting of the restricted stock units. |
| 5 | Derivative | Restricted Stock Units | 2023-02-09 | M | D | 4,967 | $0.00 | 4,967 | D | $0.00 · — to — | 4,967 Common Stock | (F3) The restricted stock units vest in three ratable annual installments beginning February 9, 2022. |
| 6 | Derivative | Restricted Stock Units | 2023-02-09 | M | D | 5,833 | $0.00 | 11,667 | D | $0.00 · — to — | 5,833 Common Stock | (F2) The restricted stock units vest in three ratable annual installments beginning February 9, 2023. |